Zobrazeno 1 - 10
of 145
pro vyhledávání: '"JA Bianco"'
Autor:
L Bakke, George B. McDonald, FR Appelbaum, Raleigh A. Bowden, Jack W. Singer, Buckner Cd, Reginald A. Clift, JA Bianco, William I. Bensinger, Mark M. Schubert
Publikováno v:
Blood. 82:2025-2030
This study evaluated the effect of pentoxifylline (PTX) on the incidence of regimen-related toxicity in patients receiving allogeneic marrow transplants from related donors. All patients received a regimen of methotrexate and cyclosporine as prophyla
Autor:
Fisher, Howard M. Shulman, Rainer Storb, Theodore C. Graham, Paul A. Brown, Friedrich Schuening, FR Appelbaum, JA Bianco, B. M. Sandmaier, H. J. Deeg
Publikováno v:
Blood. 80:1608-1613
166Holmium ethylenediaminetetramethylene phosphonic acid (166Ho-EDTMP) is a short-lived beta-emitting radionuclide complexed to an aminophosphonate ligand that we have investigated in a canine model as a potential agent for specific marrow ablation b
Autor:
P. Martin, Rainer Storb, Buckner Cd, J. Nemunaitis, JA Bianco, Jean E. Sanders, M Mori, N Onetto, Claudio Anasetti, Keith M. Sullivan
Publikováno v:
Blood. 79:2572-2577
The safety and possible efficacy of recombinant human granulocyte- macrophage colony-stimulating factor (rhGM-CSF) were evaluated in 40 consecutive patients who received transplants from unrelated donors. rhGM-CSF was administered by 2-hour daily int
Autor:
Kathleen Shannon-Dorcy, Buckner Cd, Celestia S. Higano, Howard M. Shulman, JA Bianco, E Groves, J Nemunaitis, Rainer Storb, Joel D. Meyers, Motomi Mori
Publikováno v:
Blood. 78:907-913
A phase I dose escalation trial of recombinant human macrophage colony- stimulating factor (rhM-CSF) in combination with conventional antifungal therapy was conducted in 24 marrow transplant recipients with invasive fungal infection. Daily doses rang
Autor:
RA Clift, JA Bianco, FR Appelbaum, CD Buckner, JW Singer, L Bakke, WI Bensinger, RA Bowden, GB McDonald, M Schubert
Publikováno v:
Blood. 82(7)
This study evaluated the effect of pentoxifylline (PTX) on the incidence of regimen-related toxicity in patients receiving allogeneic marrow transplants from related donors. All patients received a regimen of methotrexate and cyclosporine as prophyla
Autor:
FR Appelbaum, PA Brown, BM Sandmaier, R Storb, DR Fisher, HM Shulman, TC Graham, FG Schuening, HJ Deeg, JA Bianco
Publikováno v:
Blood. 80(6)
166Holmium ethylenediaminetetramethylene phosphonic acid (166Ho-EDTMP) is a short-lived beta-emitting radionuclide complexed to an aminophosphonate ligand that we have investigated in a canine model as a potential agent for specific marrow ablation b
Autor:
JA Bianco, Irwin D. Bernstein, C. Anasetti, Friedrich Schuening, C. D. Buckner, B. M. Sandmaier, Christopher C. Badger, F. B. Petersen, P. Martin, R. Storb, FR Appelbaum, E. D. Thomas, J. Hansen
Publikováno v:
Organ Transplantation 1990 ISBN: 9780792311911
The ideal conditioning regimen for marrow transplants both destroys the underlying malignant disease and abrogates host immunity sufficiently to prevent rejection of the graft without undue toxicity. Unfortunately, such a regimen does not exist. A co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24c341374770e8557ad93c715183ad4d
https://doi.org/10.1007/978-94-011-3386-9_58
https://doi.org/10.1007/978-94-011-3386-9_58
Publikováno v:
Blood. 78:533-534
Autor:
Harter LM; School of Communication Studies, Ohio University., Bianco JA; Department of Social Medicine, Ohio University., Cameron C; School of Communication Studies, Ohio University.
Publikováno v:
Health communication [Health Commun] 2024 Mar 12, pp. 1-4. Date of Electronic Publication: 2024 Mar 12.
Autor:
Harter LM; School of Communication Studies, Ohio University Scripps College of Communication., Kaminski CW; School of Communication Studies, Ohio University Scripps College of Communication., Mitchell P; Passion Works Studio., Dlouhy S; Passion Works Studio., Semsel T; Passion Works Studio., Bianco JA; Department of Social Medicine, Ohio University Heritage College of Osteopathic Medicine.
Publikováno v:
Health communication [Health Commun] 2023 Mar; Vol. 38 (3), pp. 631-635. Date of Electronic Publication: 2022 Feb 20.